ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $230,217 (100.0% shares, 0.0% debt)

Holdings (9)

BEAM BEAM THERAPEUTICS INC. 48.9%

Value ($000) $112,595 Shares 4,540,132 Est. Cost $24.56 Unrealized +3.9%

RAPP RAPPORT THERAPEUTICS, INC. 28.7%

Value ($000) $66,148 Shares 3,728,738 Est. Cost $23.15 Unrealized -4.3%

ERAS ERASCA, INC. 12.1%

Value ($000) $27,749 Shares 11,055,554 Est. Cost $17.12 Unrealized -84.0%

— VERVE THERAPEUTICS, INC. 4.9%

Value ($000) $11,330 Shares 2,008,809 Est. Cost $36.87 Unrealized —

GOSS GOSSAMER BIO, INC. 3.2%

Value ($000) $7,287 Shares 8,055,916 Est. Cost $1.15 Unrealized -25.6%

— SINGULAR GENOMICS SYSTEMS, INC. 1.1%

Value ($000) $2,460 Shares 126,630 Est. Cost $8.45 Unrealized —

QTTB Q32 BIO INC. 0.5%

Value ($000) $1,102 Shares 320,482 Est. Cost $13.78 Unrealized +129.2%

— UNITY BIOTECHNOLOGY, INC. 0.4%

Value ($000) $981 Shares 1,004,817 Est. Cost $0.40 Unrealized —

— CERO THERAPEUTICS HOLDINGS, INC. 0.2%

Value ($000) $564 Shares 9,393,561 Est. Cost $0.52 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BEAM	BEAM THERAPEUTICS INC.	4,540,132	$112,595	48.9%	$24.56	+3.9%	COM	07373V105
RAPP	RAPPORT THERAPEUTICS, INC.	3,728,738	$66,148	28.7%	$23.15	-4.3%	COM	75383L102
ERAS	ERASCA, INC.	11,055,554	$27,749	12.1%	$17.12	-84.0%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,008,809	$11,330	4.9%	$36.87	—	COM	92539P101
GOSS	GOSSAMER BIO, INC.	8,055,916	$7,287	3.2%	$1.15	-25.6%	COM	38341P102
—	SINGULAR GENOMICS SYSTEMS, INC.	126,630	$2,460	1.1%	$8.45	—	COM NEW	82933R308
QTTB	Q32 BIO INC.	320,482	$1,102	0.5%	$13.78	+129.2%	COM	746964105
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$981	0.4%	$0.40	—	COM NEW	91381U200
—	CERO THERAPEUTICS HOLDINGS, INC.	9,393,561	$564	0.2%	$0.52	—	CLASS A COM	71902K105